| Literature DB >> 32107428 |
Huina Liu1, Jiajia Wang1, Yukun Pan1, Yinghui Ge2, Zhiping Guo3, Shihua Zhao4.
Abstract
The aims of the study were to identify subclinical global systolic function abnormalities and evaluate influencing factors associated with left ventricular (LV) strain parameters in hypertensive subjects using cardiovascular magnetic resonance imaging feature tracking (CMR-FT). The study enrolled 57 patients with essential hypertension (mean age: 43.04 ± 10.90 years; 35 males) and 26 healthy volunteers (mean age: 38.69 ± 10.44 years; 11 males) who underwent clinical evaluation and CMR examination. Compared with controls, hypertensive patients had significantly impaired myocardial strain values while ejection fraction (EF) did not differ. After multivariate regression analyses adjustment for confounders, the global radial strains (GRS) was independently associated with the mean arterial pressure (MAP) and left ventricular mass index (LVMI) (β = -0.219, p = 0.009 and β = -0.224, p = 0.015, respectively; Adjusted R2 = 0.4); the global circumferential strains (GCS) was also independently associated with the MAP and LVMI (β = 0.084, p = 0.002 and β = 0.073, p = 0.01, respectively; Adjusted R2 = 0.439); the global longitudinal strains (GLS) was independently associated with the Age and MAP (β = 0.065, p = 0.021 and β = 0.077, p = 0.009, respectively; Adjusted R2 = 0.289). Myocardial strain can early detect the myocardial damage and may be an appropriate target for preventive strategies before abnormalities of EF.Entities:
Mesh:
Year: 2020 PMID: 32107428 PMCID: PMC7046638 DOI: 10.1038/s41598-020-60537-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Distributions of clinical and demographic parameters of the study population.
| Hypertensivepatients ( | Healthy group ( | ||
|---|---|---|---|
| Age (year) | 43.04 ± 10.90 | 38.69 ± 10.44 | 0.092 |
| Male (%) | 35(61.4) | 11 (42.3) | 0.105 |
| Height (m) | 1.68 ± 0.08 | 1.67 ± 0.07 | 0.389 |
| Weight (kg) | 76.09 ± 14.28 | 64.81 ± 10.10 | <0.001 |
| BMI (kg/m2) | 26.74 ± 3.37 | 23.33 ± 3.06 | <0.001 |
| BSA (m2) | 1.88 ± 0.21 | 1.72 ± 0.16 | 0.001 |
| Clinic SBP (mmHg) | 146.11 ± 13.44 | 110.96 ± 6.00 | <0.001 |
| Clinic DBP (mmHg) | 92.63 ± 10.29 | 71.96 ± 4.78 | <0.001 |
| MAP (mmHg) | 110.46 ± 10.76 | 84.96 ± 4.84 | <0.001 |
| Totalserumcholesterol (mmol/l) | 4.56 ± 0.81 | 4.05 ± 0.66 | 0.006 |
| Triglycerides (mmol/l) | 1.58 (1.13–2.53) | 1.33 (1.01–1.64) | 0.044 |
| LDL cholesterol (mmol/l) | 2.49 ± 0.75 | 2.14 ± 0.49 | 0.014 |
| HDL cholesterol (mmol/l) | 1.02 ± 0.28 | 1.35 ± 0.25 | <0.001 |
| Hemoglobin A1C (%) | 5.74 ± 0.41 | 5.67 ± 0.35 | 0.373 |
| Fasting blood glucose(mmol/l) | 4.68 ± 0.56 | 4.76 ± 0.43 | 0.490 |
| Heart rate (beats/min) | 72.73 ± 9.90 | 68.35 ± 7.90 | 0.051 |
Comparison of left ventricular parameters of CMR in two groups.
| Hypertensivepatients ( | Healthy group ( | ||
|---|---|---|---|
| Indexed LVEDV (ml/m2) | 63.59 ± 10.17 | 66.71 ± 7.71 | 0.168 |
| Indexed LVESV (ml/m2) | 23.54 ± 5.88 | 23.09 ± 3.86 | 0.678 |
| LVEF (%) | 63.19 ± 6.18 | 65.42 ± 4.13 | 0.056 |
| Left ventricle mass/Height (g/m) | 70.49 ± 13.24 | 53.38 ± 9.21 | <0.001 |
| Left ventricle mass /BSA (g/m2) | 63.13 ± 10.79 | 51.47 ± 7.05 | <0.001 |
| GRS (%) | 35.14 ± 7.27 | 42.14 ± 7.80 | <0.001 |
| GCS (%) | −19.64 ± 2.46 | −21.87 ± 2.42 | <0.001 |
| GLS (%) | −16.48 ± 2.34 | −17.85 ± 1.83 | 0.010 |
Comparison of variables between the two groups was performed by using the independent-sample Student’s t test. Indexed LVEDV, Indexed left ventricular enddiastolic volume; Indexed LVESV, Indexed left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; BSA, body surface area; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
Figure 1Scatter dot plots reporting the comparison of the differences in hypertensive patients and healthy controls for global radial strain (GRS) (a), global circumferential strain (GCS) (b) and global longitudinal strain (GLS) (c). The black lines represents the mean with SD. The GRS, GCS and GLS were significantly different between the two groups. *P < 0.05. GRS indicates global radial strain; GCS indicates global circumferential strain; GLS indicates global longitudinal strain.
Univariable correlations of GRS, GCS and GLS in the hypertensive patients.
| GRS | GCS | GLS | ||||
|---|---|---|---|---|---|---|
| Age (year) | −0.037 | 0.681 | 0.014 | 0.656 | 0.045 | 0.12 |
| Male (%) | −4.288 | 0.029 | 1.336 | 0.045 | 1.396 | 0.027 |
| Height (m) | −33.115 | 0.006 | 10.727 | 0.009 | 9.355 | 0.017 |
| Weight (kg) | −0.146 | 0.031 | 0.047 | 0.039 | 0.041 | 0.059 |
| BMI (kg/m2) | −0.372 | 0.201 | 0.119 | 0.224 | 0.107 | 0.255 |
| BSA (m2) | −10.446 | 0.02 | 3.373 | 0.026 | 2.968 | 0.04 |
| Clinic SBP (mmHg) | −0.228 | 0.001 | 0.086 | <0.001 | 0.075 | 0.001 |
| Clinic DBP (mmHg) | −0.348 | <0.001 | 0.124 | <0.001 | 0.084 | 0.005 |
| MAP (mmHg) | −0.331 | <0.001 | 0.121 | <0.001 | 0.090 | 0.001 |
| Totalserumcholesterol (mmol/l) | −1.949 | 0.103 | 0.535 | 0.188 | 0.299 | 0.441 |
| LDLcholesterol (mmol/l) | −0.917 | 0.487 | 0.285 | 0.523 | 0.123 | 0.773 |
| HDL cholesterol (mmol/l) | 6.334 | 0.07 | −2.416 | 0.04 | −0.815 | 0.474 |
| Hemoglobin A1C (%) | −1.374 | 0.563 | 0.638 | 0.426 | 0.257 | 0.737 |
| Fasting blood glucose (mmol/l) | −1.188 | 0.497 | 0.323 | 0.585 | 0.584 | 0.298 |
| Heart rate (beats/min) | −0.148 | 0.133 | 0.059 | 0.077 | 0.023 | 0.466 |
| Left ventricle mass/Height (g/m) | −0.314 | <0.001 | 0.107 | <0.001 | 0.072 | 0.002 |
| Left ventricle mass /BSA (g/m2) | −0.366 | <0.001 | 0.125 | <0.001 | 0.081 | 0.004 |
GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain; BMI, body mass index; BSA, body surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure, LDL cholesterol, low density lipoprotein cholesterol; HDL cholesterol, high density lipoprotein cholesterol.
Figure 2Scatter plots of global radial strain (GRS) (a), global circumferential strain (GCS) (b) and global longitudinal strain (GLS) (c) against mean arterial pressure (MAP), linear regression estimates with 95% confidence limits (black lines with gray shades). GRS indicates global radial strain; GCS indicates global circumferential strain; GLS indicates global longitudinal strain; MAP indicates mean arterial pressure.
Multiple Linear Regression Analysis of Left Ventricular Strain in Hypertension Group.
| GRS | GCS | GLS | ||||
|---|---|---|---|---|---|---|
| ( | ( | ( | ||||
| Age (year) | −0.054 | 0.496 | 0.018 | 0.474 | 0.065 | 0.021 |
| Male | 0.075 | 0.972 | −0.12 | 0.866 | 0.579 | 0.446 |
| BSA (m2) | −9.132 | 0.071 | 3.013 | 0.068 | 3.198 | 0.07 |
| MAP (mmHg) | −0.219 | 0.009 | 0.084 | 0.002 | 0.077 | 0.009 |
| HDL cholesterol (mmol/l) | 4.254 | 0.129 | −1.744 | 0.058 | — | — |
| Left ventricle mass/BSA(g/m2) | −0.224 | 0.015 | 0.073 | 0.015 | 0.016 | 0.602 |
GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain; BSA, body surface area; MAP, mean arterial pressure, HDL cholesterol, high density lipoprotein cholesterol.
Intra- and inter-observer agreement in strain measurement.
| Mean difference | Limits of agreement | ||
|---|---|---|---|
| Intra-observer | 0.46 | −4.15–5.07 | 0.946 (0.871–0.978) |
| Inter-observer | −0.49 | −8.44–7.46 | 0.898 (0.762–0.958) |
| Intra-observer | −0.18 | −1.05–0.68 | 0.978 (0.944–0.991) |
| Inter-observer | 0.05 | −1.16–1.26 | 0.977 (0.939–0.991) |
| Intra-observer | −0.25 | −1.50–1.00 | 0.970 (0.923–0.988) |
| Inter-observer | 0.03 | −0.85–0.91 | 0.960 (0.902–0.984) |
GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
Figure 3Bland-Altman plots of the intra- and inter-observer reproducibility for GRS (a,d), GCS (b,e) and GLS (c,f) measured by CMR-FT. The Bland-Altman plots include the line of equality, the line of mean difference, the lines of the 95% confidence interval of mean of differences and the lines of the 95% limits of agreement. GRS indicates global radial strain; GCS indicates global circumferential strain; GLS indicates global longitudinal strain.
Figure 4LV feature tracking analysis (1) Iidentify end-diastolic phase (reference phase); (2) The endo- and epicardial borders were automatically drew in the end-diastolic phase using SAX slices (a-e) and long axis 2-, 3- and 4-chamber slices (f–h), which could be manually adjusted if poor tracking; (3) Then, the software algorithm automatically drew the borders and traced the myocardium voxel points throughout the other cardiac phases during a cardiac cycle based on the endo- and epicardial contours of reference phase; (4) Finally, the 2D strain values were calculated automatically.